Market Research Logo

Global Single-use Bioprocessing System Market 2017-2021

Global Single-use Bioprocessing System Market 2017-2021

About Single-Use Bioprocessing System

The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products. Bioprocess is a technique that produces biological materials such as a genetically engineered microbial strain for commercial use. For example, commercially useful chemicals are produced through bioprocess techniques such as microbial fermentation or degradation. The traditional approaches in bioprocessing involve stainless steel equipment that are not just difficult to maintain but also time-consuming and costly.

Technavio’s analysts forecast the global single-use bioprocessing system market to grow at a CAGR of 7.83% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global single-use bioprocessing system market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of key vendors to end-users such as pharmaceutical companies, CROs/CMOs, biotech companies, and academic and research institutions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Single-Use Bioprocessing System Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific
Other prominent vendors
  • Broadley-James Corporation
  • Eppendorf
  • Saint-Gobain
Market driver
  • Single-use technology (SUT) combats global drug shortage problem.
  • For a full, detailed list, view our report
Market challenge
  • Risk of leachables and extractables from plastics used in disposable systems.
  • For a full, detailed list, view our report
Market trend
  • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stages.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Single-Use Bioprocessing System Market 2017-2021

Technavio recognizes the following companies as the key players in the global single-use bioprocessing system market: Danaher, GE Healthcare, Merck, Sartorius, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Broadley-James Corporation, Eppendorf, and Saint-Gobain.

Commenting on the report, an analyst from Technavio’s team said: “One trend in market is increasing adoption of single-use bioprocessing in pre-clinical and commercial stage. Single-use bioprocess systems have currently established themselves as the accepted choice at both the pre-clinical and bioproduction stage. Biopharmaceutical companies are increasingly accepting these systems as a trusted alternative at the commercial stage to accelerate the production process.”

According to the report, one driver in market is SUT combats global drug shortage problem. The biopharmaceutical industry is shifting toward SUTs to combat the global drug shortage. Companies struggle to meet clinical trial timelines and invariably suffer losses, which could be avoided. The growing evidence of sterility, along with regulatory organizations encouraging pharma companies to switch to single-use technologies, hints toward a transition. Companies that have integrated and shifted toward a single-use system have expressed their satisfaction in terms of lower costs, reduced overall contamination rates, and enhanced production throughput efficiency. While using SUTs, companies spend lesser time with disassembly and clean-up of the system, resulting in a quicker turnaround time for new batches of medications. SUT allows for continuous manufacturing and saves the companies production time. This translates to huge cost savings, which the pharma companies can use in other aspects of drug development. Thus, single-use technology is the most cost-efficient solution to increase rapidity in drug development, support larger batches of production, and achieve a quicker time to market the solutions.

Further, the report states that one challenges in market is lack of standardization across suppliers. The absence of standardization in equipment is a key challenge for end-users in the single-use bioprocessing systems market, despite the advantages of cost and faster implementation. Generally, components sourced from one supplier cannot be used with components from another due to lack of compatibility and different materials used by suppliers to manufacture the same equipment. This is forcing vendors to stick to one supplier or purchase duplicate versions of same components, which is increasing their inventory management costs. Some suppliers have stated the reasons for the absence of standardization, which is because vendors are customizing equipment according to their respective needs, which leads to additional charge from the supplier's side. For example, a customized assembly would cost more in comparison to off-the-shelf assembly when solutions have to be adjusted to a certain manufacturing site.

Companies Mentioned

Danaher, GE Healthcare, Merck, Sartorius, Thermo Fisher Scientific, Broadley-James Corporation, Eppendorf, and Saint-Gobain.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Advantages of single-use technologies over stainless steel technology
    • Market size and forecast
      • Table Global single-use bioprocessing systems market ($ billions)
      • Table Ongoing trends in biopharmaceutical industry impacting the adoption of single-use technologies
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • Market overview
      • Table Global single-use bioprocessing systems market by application 2016-2021 (%)
    • mAB production
      • Table Global single-use bioprocessing systems market for mAB production 2016-2021 ($ millions)
    • Vaccine production
      • Table Global single-use bioprocessing systems market for vaccine production 2016-2021 ($ millions)
    • Plant cell cultivation
      • Table Global single-use bioprocessing systems market for plant cell cultivation 2016-2021 ($ millions)
    • PSCTs
      • Table Global single-use bioprocessing systems market for PSCTs 2016-2021 ($ millions)
    • Others
      • Table Global single-use bioprocessing systems market for other applications 2016-2021 ($ millions)
  • Market segmentation by product type
    • Market overview
      • Table Global single-use bioprocessing systems market by product type 2016-2021 (%)
    • Bags and mixers
      • Table Global single-use bags and mixers market 2016-2021 ($ millions)
    • Bioreactors and fermenters
      • Table Global SUBs and fermenters market 2016-2021 ($ millions)
    • Filtration devices and sampling systems
      • Table Global single-use filtration devices and sampling systems market 2016-2021 ($ millions)
    • Bioprocess containers
      • Table Global single-use bioprocess containers market 2016-2021 ($ millions)
    • Tubing systems (connectors/pipes)
      • Table Global single-use tubing systems market 2016-2021 ($ millions)
    • Others
      • Table Global single-use others market 2016-2021 ($ millions)
  • Market segmentation by end-users
    • Market overview
      • Table Global single-use bioprocessing systems market by end-users 2016 and 2021
    • Pharmaceutical companies
      • Table Pharmaceutical companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
    • CROs & CMOs
      • Table CROs and CMOs in global single-use bioprocessing systems market 2016-2021 ($ millions)
    • Biotechnology companies
      • Table Biotech companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
    • Academic and research institutions
      • Table Academic and research institutions in global single-use bioprocessing systems market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Global single-use bioprocessing systems market by geography 2016-2021
    • Market overview
    • Americas
      • Table Single-use bioprocessing systems market in Americas 2016-2021 ($ billions)
    • EMEA
      • Table Single-use bioprocessing systems market in EMEA 2016-2021 ($ billions)
    • APAC
      • Table Single-use bioprocessing systems market in APAC 2016-2021 ($ billions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Recent M&As in the single-use bioprocessing systems market
    • Impact of drivers on key customer segments
      • Table Impact of drivers
    • Market challenges
    • Impact of challenges on key customer segments
      • Table Impact of challenges
  • Market trends
    • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stage
      • Table Advantages of implementing single-use bioprocessing systems
    • Emergence of downstream disposables
    • SUT aiding continuous bioprocessing
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factor of consideration for companies
  • Key vendor analysis
    • Danaher
      • Table Danaher: Profile
      • Table Danaher: Strength analysis
      • Table Danaher: Strategy assessment
      • Table Danaher: Opportunity assessment
    • GE Healthcare
      • Table GE Healthcare: Profile
      • Table GE Healthcare: Strength analysis
      • Table GE Healthcare: Strategy assessment
      • Table GE Healthcare: Opportunity assessment
    • Merck
      • Table Merck: Profile
      • Table Merck: Strength analysis
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Sartorius
      • Table Sartorius: Profile
      • Table Sartorius: Strength analysis
      • Table Sartorius: Strategy assessment
      • Table Sartorius: Opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Profile
      • Table Thermo Fisher Scientific: Strength analysis
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report